Vbcf.ac.at Website Review

access to state-of-the-art research infrastructure and scientific services. access to state-of-the-art research infrastructure and scientific services. access to state-of-the-art research infrastructure and scientific services.. we enable scientists to achieve their goals by providing access to cutting-edge research infrastructure in the field of biomedical. we keep our resources, technology, and expertise at the highest level in order to stay at the forefront of science. the vienna biocenter core facilities (vbcf) have been publicly funded by the austrian federal ministry of education, science and research. ares genetics teams up with leading global pharma company in fight against antibiotic resistance. valneva initiates phase 2 clinical development for its lyme disease vaccine candidate. hookipa doses first patient in a phase 2 clinical trial of prophylactic vaccine candidate hb-101 against cytomegalovirus. large infrastructure project phenoplant for phenotyping of crop plants approved. czedik-eysenberg, a., seitner, s., güldener, u., koemeda, s., jez, j., colombini, m., & djamei, a. groessl f., munsch t., meis s., griessner j., kaczanowska j., pliota p., kargl d., badurek s., kraitsy k., ras*oulpour a., zuber j., lessmann v., haubensak w. 2018, nat. neuroscience 21(7):952-62. stolt-bergner p, benda c, bergbrede t, besir h, celie phn, chang c, drechsel d, fischer a, geerlof a, giabbai b, van den heuvel j, huber g, knecht w, lehner a, lemaitre r, nordén k, pardee g, racke i, remans k, sander a, scholz j, stadnik m, et al. bian s, repic m, guo z, kavirayani a, burkard t, bagley ja, krauditsch c & kn*blich ja muhar m, ebert a, neumann t, umkehrer c, jude j, wieshofer c, rescheneder p, lipp jj, herzog va, reichholf b, cisneros da, hoffmann t, schlapansky mf, bhat p, von haeseler a, köcher t, obenauf ac, popow j, ameres sl, zuber j. research infrastructures – a key instrument in advancement of knowledge and technology.